BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Nov 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-11-25

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-25	Common Stock	M	20000	$26.49	Acquired	84426	Direct
2014-11-25	Common Stock	S	20000	$89.75	Disposed	64426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-25	Stock Option (right to buy) Common Stock	$89.75	M	20000	Disposed	2021-05-11	Common Stock (20000)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed August 20, 2014

F2: All shares sold at same price

F3: Original option grant vests 6/48ths on November 12, 2011 and 1/48th on the 12th day of every month thereafter

F4: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.